Despite the incredible efficacy of oral pre-exposure prophylaxis (PrEP) and 78 countries currently offering PrEP in some form, its effectiveness at reducing HIV incidence in the real world has been dependent on far-reaching factors that go beyond how well PrEP is able to prevent HIV acquisition at a cellular level: political leadership, quality health services… Read More »
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »
getty An excellent article in The New York Times, “A Warning for the United States From the Author of ‘The Great Influenza’” by John M. Barry, professor of public health at Tulane University and author of several books on historic pandemics, sets out the priorities for the future, and above all highlights the false dichotomy… Read More »
It’s a bit like waking from a disturbing dream. As you open your eyes, the outlines of the room and the furniture are familiar, the world looks more or less unchanged, but everything feels unmistakably different. nd so it is as we emerge after lockdown. A bit disorientated, a bit out of step. For months… Read More »
There are so many ads on television promoting the use of testosterone for men who have sexual problems such as poor erections and/or low libido. Yes testosterone will help with these problems but at a price. Testosterone supplementation increases the risk of having serious blood clots. In fact a study in JAMA Internal Medicine… Read More »